|
1
|
Stumvoll M, Goldstein BJ and van Haeften
TW: Type 2 diabetes: Principles of pathogenesis and therapy.
Lancet. 365:1333–1346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng Y, Ley SH and Hu FB: Global
aetiology and epidemiology of type 2 diabetes mellitus and its
complications. Nat Rev Endocrinol. 14:88–98. 2018. View Article : Google Scholar
|
|
3
|
Garabadu D and Krishnamurthy S: Metformin
attenuates hepatic insulin resistance in type-2 diabetic rats
through PI3K/Akt/GLUT-4 signalling independent to
bicuculline-sensitive GABAA receptor stimulation. Pharm
Biol. 55:722–728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Thakran S, Bheemreddy R, Coppess
W, Walker RJ and Steinle JJ: Sodium salicylate reduced insulin
resistance in the retina of a type 2 diabetic rat model. PLoS One.
10:e01255052015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu X, Wu YB, Zhou J and Kang DM:
Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via
increasing FoxO1 expression. Biochem Biophys Res Commun.
469:319–325. 2016. View Article : Google Scholar
|
|
6
|
Burchell A: Glycogen storage diseases and
the liver. Baillieres Clin Gastroenterol. 12:337–354. 1998.
View Article : Google Scholar
|
|
7
|
Pan T, Guo JH, Ling L, Qian Y, Dong YH,
Yin HQ, Zhu HD and Teng GJ: Effects of Multi-electrode renal
denervation on insulin sensitivity and glucose metabolism in a
canine model of type 2 diabetes mellitus. J Vasc Interv Radiol.
29:731–738.e2. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li P, Ruan X, Yang L, Kiesewetter K, Zhao
Y, Luo H, Chen Y, Gucek M, Zhu J and Cao H: A liver-enriched long
non-coding RNA, lncLSTR, regulates systemic lipid metabolism in
mice. Cell Metab. 21:455–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morá I, Akerman İ, van de Bunt M, Xie R,
Benazra M, Nammo T, Arnes L, Nakić N, García-Hurtado J,
Rodríguez-Seguí S, et al: Human β cell transcriptome analysis
uncovers lncRNAs that are tissue-specific, dynamically regulated,
and abnormally expressed in type 2 diabetes. Cell Metab.
16:435–448. 2012. View Article : Google Scholar
|
|
11
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oh KJ, Han HS, Kim MJ and Koo SH: CREB and
FoxO1: Two transcription factors for the regulation of hepatic
gluconeogenesis. BMB Rep. 46:567–574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang P, Chen D, Ma H and Li Y: LncRNA MEG3
enhances cisplatin sensitivity in non-small cell lung cancer by
regulating miR-21-5p/SOX7 axis. Onco Targets Ther. 10:5137–5149.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double-stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan FY, Deng R, Yi H, Sun HP, Zeng Y, He
GC and Su Y: The inhibitory effect of MEG3/miR-214/AIFM2 axis on
the growth of T-cell lymphoblastic lymphoma. Int J Oncol.
51:316–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li K, Zhang J, Yu J, Liu B, Guo Y, Deng J,
Chen S, Wang C and Guo F: MicroRNA-214 suppresses gluconeogenesis
by targeting activating transcriptional factor 4. J Biol Chem.
290:8185–8195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Meng Q, Xiao F, Chen S, Du Y, Yu J,
Wang C and Guo F: ATF4 deficiency protects mice from
high-carbohydrate-diet-induced liver steatosis. Biochem J.
438:283–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsumoto M, Pocai A, Rossetti L, Depinho
RA and Accili D: Impaired regulation of hepatic glucose production
in mice lacking the forkhead transcription factor foxo1 in liver.
Cell Metabolism. 6:208–216. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang W, Yu J, Jia X, Xiong L, Li N and
Wen X: Zhenqing recipe improves glucose metabolism and insulin
sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats. Am
J Chin Med. 40:721–733. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang J, Liu C, Qiao A, Cui Y, Zhang H,
Cui A, Zhang S, Yang Y, Xiao X, Chen Y, et al: MicroRNA-29a-c
decrease fasting blood glucose levels by negatively regulating
hepatic gluconeogenesis. J Hepatol. 58:535–542. 2013. View Article : Google Scholar
|
|
21
|
Morris EM, Meers GM, Booth FW, Fritsche
KL, Hardin CD, Thyfault JP and Ibdah JA: PGC-1α overexpression
results in increased hepatic fatty acid oxidation with reduced
triacylglycerol accumulation and secretion. Am J Physiol
Gastrointest Liver Physiol. 303:G979–G992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galbo T, Perry RJ, Nishimura E, Samuel VT,
Quistorff B and Shulman GI: PP2A inhibition results in hepatic
insulin resistance despite Akt2 activation. Aging (Albany NY).
5:770–781. 2013. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Bunn RC, Cockrell GE, Ou Y, Thrailkill KM,
Lumpkin CK Jr and Fowlkes JL: Palmitate and insulin synergistically
induce IL-6 expression in human monocytes. Cardiovasc Diabetol.
9:732010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Volpe CM, Abreu LF, Gomes PS, Gonzaga RM,
Veloso CA and Nogueiramachado JA: The production of nitric oxide,
IL-6, and TNF-alpha in palmitate-stimulated PBMNCs is enhanced
through hyperglycemia in diabetes. Oxid Med Cell Longev.
2014.479587:2014.
|
|
26
|
Gross DN, Wan M and Birnbaum MJ: The role
of FOXO in the regulation of metabolism. Curr Diab Rep. 9:208–214.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin N, Tong GF, Sun LW and Xu XL: Long
noncoding RNA MEG3 suppresses glioma cell proliferation, migration,
and invasion by acting as a competing endogenous RNA of miR-19a.
Oncol Res. 25:1471–1478. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ying L, Huang Y, Chen H, Wang Y, Xia L,
Chen Y, Liu Y and Qiu F: Downregulated MEG3 activates autophagy and
increases cell proliferation in bladder cancer. Mol Biosyst.
9:407–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH
and Guo RH: Decreased expression of long noncoding RNA MEG3 affects
cell proliferation and predicts a poor prognosis in patients with
colorectal cancer. Tumour Biol. 36:4851–4859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu MH, Tang B, Zeng S, Hu CJ, Xie R, Wu
YY, Wang SM, He FT and Yang SM: Long noncoding RNA BC032469, a
novel competing endogenous RNA, upregulates hTERT expression by
sponging miR-1207-5p and promotes proliferation in gastric cancer.
Oncogene. 35:3524–3534. 2016. View Article : Google Scholar
|
|
32
|
Peng W, Si S, Zhang Q, Zhao F, Wang F, Yu
J and Ma R: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate gastric cancer progression. J Exp Clin
Cancer Res. 34:792015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan H, Rao J, Yuan J, Gao L, Huang W, Zhao
L and Ren J: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate ischemic neuronal death by targeting
miR-21/PDCD4 signaling pathway. Cell Death Dis. 8:32112017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuzaki H, Daitoku H, Hatta M, Tanaka K
and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1)
targets to proteasomal degradation. Proc Natl Acad Sci USA.
100:11285–11290. 2003. View Article : Google Scholar : PubMed/NCBI
|
